Follow Us On
Capsule
Files
Oseltamivir Phosphate
Strength: 75mg
Count: 10
NDC
42291-664-10
Class
Rx
Brand Name
Tamiflu
Imprint Code
AMNEAL;266
Color(s)
YELLOW (yellow opaque cap), GRAY (light gray opaque body)
Shape
CAPSULE
Score
no score
Case Count
NA
Inactive Ingredients
croscarmellose sodium, povidone K-30, pregelatinized starch (maize), stearic acid, and talc. The capsule shell contains black iron oxide, gelatin, titanium dioxide, and yellow iron oxide.
Indications and Usage
1. Treatment of Influenza Oseltamivir phosphate capsules are indicated for the treatment of acute, uncomplicated illness due to influenza A and B infection in patients 2 weeks of age and older who have been symptomatic for no more than 48 hours. 2. Prophylaxis of Influenza Oseltamivir phosphate capsules are indicated for the prophylaxis of influenza A and B in patients 1 year and older. 3. Limitations of Use • Oseltamivir phosphate capsules are not a substitute for early influenza vaccination on an annual basis as recommended by the Centers for Disease Control and Prevention Advisory Committee on Immunization Practices. • Influenza viruses change over time. Emergence of resistance substitutions could decrease drug effectiveness. Other factors (for example, changes in viral virulence) might also diminish clinical benefit of antiviral drugs. Prescribers should consider available information on influenza drug susceptibility patterns and treatment effects when deciding whether to use oseltamivir phosphate capsules. • Oseltamivir phosphate capsules are not recommended for patients with end-stage renal disease not undergoing dialysis.
